K. Fichte

827 total citations
31 papers, 646 citations indexed

About

K. Fichte is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, K. Fichte has authored 31 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cognitive Neuroscience, 9 papers in Psychiatry and Mental health and 6 papers in Experimental and Cognitive Psychology. Recurrent topics in K. Fichte's work include Sleep and Wakefulness Research (7 papers), Sleep and related disorders (5 papers) and Epilepsy research and treatment (5 papers). K. Fichte is often cited by papers focused on Sleep and Wakefulness Research (7 papers), Sleep and related disorders (5 papers) and Epilepsy research and treatment (5 papers). K. Fichte collaborates with scholars based in Germany, Austria and United States. K. Fichte's co-authors include W.M. Herrmann, St. Kubicki, Gerhard Freund, Georg Ferber, K. Abt, Theodora Duka, M. Sastre-y-Hernández, R. Luthringer, G. Hebenstreit and Katrin Fellerer and has published in prestigious journals such as The Lancet Neurology, Psychopharmacology and British Journal of Clinical Pharmacology.

In The Last Decade

K. Fichte

29 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Fichte Germany 11 287 228 133 111 70 31 646
Fotis Fotiou Greece 12 135 0.5× 92 0.4× 44 0.3× 91 0.8× 85 1.2× 34 590
Véronique Bragulat United States 10 177 0.6× 151 0.7× 232 1.7× 75 0.7× 75 1.1× 18 709
Stephen L. Read United States 10 232 0.8× 73 0.3× 65 0.5× 56 0.5× 180 2.6× 15 603
G. Williams United States 5 234 0.8× 239 1.0× 339 2.5× 63 0.6× 151 2.2× 9 637
Serge Bakchine France 15 246 0.9× 207 0.9× 118 0.9× 122 1.1× 238 3.4× 45 969
Yumiko Kaseda Japan 15 166 0.6× 101 0.4× 188 1.4× 28 0.3× 52 0.7× 32 473
Yan Ren China 17 167 0.6× 168 0.7× 134 1.0× 56 0.5× 50 0.7× 48 762
Celeste D. Lefebvre Canada 10 181 0.6× 172 0.8× 259 1.9× 52 0.5× 41 0.6× 12 625
E Gil-Néciga Spain 13 342 1.2× 103 0.5× 101 0.8× 63 0.6× 223 3.2× 33 706
Akira Yamashita Japan 16 289 1.0× 169 0.7× 284 2.1× 59 0.5× 66 0.9× 37 870

Countries citing papers authored by K. Fichte

Since Specialization
Citations

This map shows the geographic impact of K. Fichte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Fichte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Fichte more than expected).

Fields of papers citing papers by K. Fichte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Fichte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Fichte. The network helps show where K. Fichte may publish in the future.

Co-authorship network of co-authors of K. Fichte

This figure shows the co-authorship network connecting the top 25 collaborators of K. Fichte. A scholar is included among the top collaborators of K. Fichte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Fichte. K. Fichte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hentschel, H., et al.. (2008). Lormetazepam bei der Behandlung von Schlafstörungen in der internistischen Praxis: Doppelblindprüfung an 100 Patienten. DMW - Deutsche Medizinische Wochenschrift. 106(22). 711–714. 1 indexed citations
3.
Herrmann, Walter, et al.. (2008). Elektroenzephalographische und psychoexperimentelle Untersuchungen mit Lithium an gesunden Probanden. Pharmacopsychiatry. 13(4). 200–212. 1 indexed citations
4.
Ferber, Georg, K. Abt, K. Fichte, & R. Luthringer. (1999). IPEG Guideline on Statistical Design and Analysis for Pharmacodynamic Trials. Neuropsychobiology. 39(2). 92–100. 39 indexed citations
5.
Duka, Theodora, et al.. (1995). Effects of ZK 93 426, a β-carboline benzodiazepine receptor antagonist on night sleep pattern in healthy male volunteers. Psychopharmacology. 117(2). 178–185. 5 indexed citations
6.
Hebenstreit, G., Katrin Fellerer, K. Fichte, et al.. (1989). Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine. Pharmacopsychiatry. 22(4). 156–160. 128 indexed citations
7.
Duka, Theodora, et al.. (1988). Human studies on the benzodiazepine receptor antagonist ?-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects. Psychopharmacology. 95(4). 463–71. 16 indexed citations
8.
Ott, H., et al.. (1988). Anterograde and Retrograde Amnesia after Lormetazepam and Flunitrazepam. PubMed. 6. 180–193. 10 indexed citations
9.
Bertolino, Alessandro, et al.. (1988). Rolipram versus lmipramine in Inpatients with Major, ???Minor??? or Atypical Depressive Disorder: A Double-Blind Double-Dummy Study Aimed at Testing a Novel Therapeutic Approach. International Clinical Psychopharmacology. 3(3). 245–253. 56 indexed citations
10.
Sastre-y-Hernández, M., et al.. (1988). Sublingual lormetazepam in the treatment of sleep disorders in general practice patients. Human Psychopharmacology Clinical and Experimental. 3(2). 139–144. 2 indexed citations
11.
Ott, H., et al.. (1984). Alcohol Interaction of Lormetazepam, Mepindolol Sulphate and Diazepam Measured by Performance on the Driving Simulator. Pharmacopsychiatry. 17(2). 36–43. 15 indexed citations
12.
Pöldinger, W, M. Sastre-y-Hernández, & K. Fichte. (1983). Study with Lormetazepam as a Hypnotic in General Practice. Neuropsychobiology. 9(2-3). 135–138. 1 indexed citations
13.
Sastre-y-Hernández, M., et al.. (1982). [Drug therapy of sleep disorders in shift workers].. PubMed. 77(8). 52–5. 1 indexed citations
14.
Hentschel, H., et al.. (1981). Comparative Efficacy of Lormetazepam (Noctamid®) and Diazepam (Valium®) in 100 Out-Patients with Insomnia. Journal of International Medical Research. 9(3). 199–202. 14 indexed citations
15.
Doenicke, A., et al.. (1981). [The antagonistic effect of physostigmine on sedation by lormetazepam (author's transl)].. PubMed. 30(12). 627–32. 4 indexed citations
16.
Doenicke, Α., et al.. (1979). [Lormetazepam in preoperative sleeplessness. Dose dependance of the effect and comparison with 100 mg pentobarbital (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(1). 29–35. 2 indexed citations
17.
Fichte, K., et al.. (1979). Verbessertes Diagnoseverfahren zur Erkennung des Diabetes mellitus. Journal of Molecular Medicine. 57(3). 111–116. 1 indexed citations
18.
Kubicki, St., W.M. Herrmann, K. Fichte, & Gerhard Freund. (1979). Reflections on the Topics: EEG Frequency Bands and Regulation of Vigilance. Pharmacopsychiatry. 12(2). 237–245. 165 indexed citations
19.
20.
Fichte, K., et al.. (1978). [Serum concentrations of prolactin, growth hormone, and alpha-fetoprotein under long-term administration of an oral contraceptive containing cyproterone acetate (author's transl)].. PubMed. 38(7). 549–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026